No Data
No Data
Earnings Call Summary | Usana Health Sciences(USNA.US) Q1 2025 Earnings Conference
USANA Health Sciences Outlines 2025 Product Launch Plans and Hiya Growth Strategy
Usana Health Sciences Shares Are Trading Higher After the Company Reported Q1 Financial Results and Beat Its Adjusted EPS and Sales Estimates.
Express News | USANA Health Sciences: Continue to Monitor & Assess the Evolving Global Trade Environment, Including Imposition of US Tariffs
USANA Health Sciences Had Direct Selling Active Customers of 459,000 Versus 494,000 >USNA
USANA Health Sciences Non-GAAP EPS of $0.73 Beats by $0.03, Revenue of $249.54M Beats by $6.5M